Compendia Bioscience: Seeking to share the risk in developing cancer drugs
At BIO-Europe 2009, Compendia Bioscience is searching for 10 to 20 potential partners for the risk-sharing program to identify a precisely targeted patient population for a partner’s innovative cancer therapeutic, in exchange for future milestone and/or royalty payments for the successful drug. Read more »